BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li X, Cai H, Wu X, Li L, Wu H, Tian R. New Frontiers in Molecular Imaging Using Peptide-Based Radiopharmaceuticals for Prostate Cancer. Front Chem 2020;8:583309. [PMID: 33335885 DOI: 10.3389/fchem.2020.583309] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Silva MJSA, Vinck R, Wang Y, Saubaméa B, Tharaud M, Dominguez-Jurado E, Karges J, Gois PMP, Gasser G. Towards Selective Delivery of a Ruthenium(II) Polypyridyl Complex-Containing Bombesin Conjugate into Cancer Cells. Chembiochem 2023;24:e202200647. [PMID: 36479913 DOI: 10.1002/cbic.202200647] [Reference Citation Analysis]
2 DeRidder L, Rubinson DA, Langer R, Traverso G. The past, present, and future of chemotherapy with a focus on individualization of drug dosing. J Control Release 2022;352:840-60. [PMID: 36334860 DOI: 10.1016/j.jconrel.2022.10.043] [Reference Citation Analysis]
3 Bispo ACA, Almeida FAF, Silva JB, Mamede M. Peptides Radiofluorination: Main Methods and Highlights. IJOC 2022;12:161-172. [DOI: 10.4236/ijoc.2022.124013] [Reference Citation Analysis]
4 Slabáková E, Kahounová Z, Procházková J, Souček K. Regulation of Neuroendocrine-like Differentiation in Prostate Cancer by Non-Coding RNAs. Noncoding RNA 2021;7:75. [PMID: 34940756 DOI: 10.3390/ncrna7040075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Mansi R, Nock BA, Dalm SU, Busstra MB, van Weerden WM, Maina T. Radiolabeled Bombesin Analogs. Cancers (Basel) 2021;13:5766. [PMID: 34830920 DOI: 10.3390/cancers13225766] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
6 Nock BA, Kaloudi A, Kanellopoulos P, Janota B, Bromińska B, Iżycki D, Mikołajczak R, Czepczynski R, Maina T. [99mTc]Tc-DB15 in GRPR-Targeted Tumor Imaging with SPECT: From Preclinical Evaluation to the First Clinical Outcomes. Cancers (Basel) 2021;13:5093. [PMID: 34680243 DOI: 10.3390/cancers13205093] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]